Pictet & Cie (Europe) Sa Jazz Pharmaceuticals PLC Transaction History

Pictet & Cie (Europe) Sa

  • $4.53 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 13, 2020
SELL
$95.68 - $121.88 $206,477 - $263,017
-2,158 Closed
0 $0
Q1 2020

Apr 30, 2020
SELL
$87.74 - $152.74 $53,433 - $93,018
-609 Reduced 22.01%
2,158 $215,000
Q4 2019

Jan 31, 2020
BUY
$117.65 - $153.73 $325,537 - $425,370
2,767 New
2,767 $413,000

Others Institutions Holding JAZZ

# of Institutions
516
Shares Held
57.8M
Call Options Held
188K
Put Options Held
110K
View Full List

About Jazz Pharmaceuticals plc

JAZZ Quotes by TradingView
  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.54B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Pictet & Cie (Europe) Sa Portfolio

Follow Pictet & Cie (Europe) Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet & Cie (Europe) Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet & Cie (Europe) Sa with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email